EMPiRE
Showing 201 - 205 of 205
Crohn's Disease Trial in United States (Double-blind (DB) adalimumab , DB adalimumab 40 mg eow, DB adalimumab 40 mg ew)
Completed
- Crohn's Disease
- Double-blind (DB) adalimumab placebo
- +3 more
-
Berkeley, California
- +42 more
Apr 7, 2011
Crohn's Disease Trial in United States (Adalimumab 40 mg eow or ew)
Completed
- Crohn's Disease
- Adalimumab 40 mg eow or ew
-
Berkeley, California
- +42 more
Apr 7, 2011
Campath and Rebif Treatment on Cognition in Multiple Sclerosis
Unknown status
- Relapsing Remitting Multiple Sclerosis
-
Berkely, California
- +6 more
Jun 4, 2009
Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease Trial in Worldwide (CGT-2168 (clopidogrel 75
Terminated
- Acute Coronary Syndrome
- +3 more
- CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin
- Plavix (clopidogrel 75 mg) and aspirin
-
Alexander City, Alabama
- +490 more
Jan 27, 2009
Crohn's Disease Trial in United States (Adalimumab (D2E7))
Completed
- Crohn's Disease
- Adalimumab (D2E7)
-
Berkeley, California
- +42 more
Aug 11, 2006